MedPath

Prognosis of Nutritional Status for Surgical Peri Hilar Cholangiocarcinoma

Conditions
Perihilar Cholangiocarcinoma
Interventions
Other: Nutritional evaluation
Registration Number
NCT04846192
Lead Sponsor
Central Hospital, Nancy, France
Brief Summary

Curative treatment of peri hilar cholangiocarcinomas is R0 surgery and require major hepatectomy with biliary tract resection. These complexe procedures can lead to high morbidity and mortality. A severe alteration of nutritional status before the surgery might be a poor prognosis for survival.

Detailed Description

Peri hilar cholangiocarcinomas are rare tumors, which when diagnosed at the resectable stage, require major hepatic resection associated with biliary reconstruction. These are complex procedures with a high morbidity and mortality, mainly due to postoperative hepatic failure and sepsis.

These patients undergo optimization of liver function with portal embolization according to the volume of the future remaining liver and preoperative biliary drainage. On top of technical challenges of the surgery, the patients usually present a significant alteration of the general condition at the time of diagnosis, with denutrition that can be severe. The importance of evaluating the preoperative nutritional status in the context of oncological surgery is increasingly recognized in the literature. Different nutritional scores exist such as the CONUT score, PNI, or the evaluation of sarcopenia on imaging examinations and have shown an impact on morbi-mortality in liver surgery.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Surgical peri hilar cholangiocarcinoma from 01/01/2003 to 04/01/2021 at Nancy University Hospital
Exclusion Criteria
  • Non curative surgery

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
PatientsNutritional evaluation-
Primary Outcome Measures
NameTimeMethod
Overall Survival01/01/2003 to 04/01/2021
Disease Free Survival01/01/2003 to 04/01/2021
Secondary Outcome Measures
NameTimeMethod
Morbidity01/01/2003 to 04/01/2021

Post operative complications : Dindo-Clavien \> or = 3

Trial Locations

Locations (1)

CHRU de Nancy

🇫🇷

Vandœuvre-lès-Nancy, France

© Copyright 2025. All Rights Reserved by MedPath